HOOK HOOKIPA Pharma Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

HOOK [NASD]

HOOKIPA Pharma Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-1.90	Insider Own	0.30%	Shs Outstand	25.63M	Perf Week	-0.38%
Market Cap	286.82M	Forward P/E	-	EPS next Y	-1.94	Insider Trans	-18.87%	Shs Float	18.59M	Perf Month	-1.87%
Income	-44.60M	PEG	-	EPS next Q	-0.47	Inst Own	61.30%	Short Float	4.41%	Perf Quarter	16.78%
Sales	13.40M	P/S	21.40	EPS this Y	-277.10%	Inst Trans	0.08%	Short Ratio	11.00	Perf Half Y	-23.23%
Book/sh	4.25	P/B	2.47	EPS next Y	-3.80%	ROA	-29.80%	Target Price	-	Perf Year	58.28%
Cash/sh	3.83	P/C	2.74	EPS next 5Y	4.80%	ROE	-36.50%	52W Range	5.80 - 14.37	Perf YTD	-14.06%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-41.50%	52W High	-26.84%	Beta	-
Dividend %	-	Quick Ratio	7.80	Sales past 5Y	-	Gross Margin	-	52W Low	81.21%	ATR	0.76
Employees	85	Current Ratio	7.80	Sales Q/Q	68.20%	Oper. Margin	-	RSI (14)	46.45	Volatility	5.29% 6.87%
Optionable	Yes	Debt/Eq	0.04	EPS Q/Q	-16.10%	Profit Margin	-	Rel Volume	0.40	Prev Close	10.51
Shortable	Yes	LT Debt/Eq	0.04	Earnings	May 14 BMO	Payout	-	Avg Volume	74.62K	Price	10.51
Recom	1.40	SMA20	-1.41%	SMA50	-4.89%	SMA200	4.93%	Volume	0	Change	0.00%

Sep-27-19

Initiated

H.C. Wainwright

Buy

$15

May-13-19

Initiated

RBC Capital Mkts

Outperform

$23

May-13-19

Initiated

BofA/Merrill

Buy

$17

Aug-04-20 07:00AM	HOOKIPA Pharma To Report Second Quarter 2020 Financial Results on August 13, 2020 GlobeNewswire
Aug-03-20 12:31PM	HOOKIPA Pharma Inc. (HOOK) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
07:00AM	HOOKIPA Announces Issuance of US and European Patents GlobeNewswire
Jul-23-20 03:24PM	Could The HOOKIPA Pharma Inc. (NASDAQ:HOOK) Ownership Structure Tell Us Something Useful? Simply Wall St.
Jun-22-20 07:15AM	HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB101 GlobeNewswire
Jun-19-20 07:00AM	HOOKIPA Announces Changes to its Board of Directors Resignation of Sander van Deventer GlobeNewswire
Jun-17-20 07:00AM	HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers GlobeNewswire
Jun-12-20 02:04PM	Hedge Funds Are Selling HOOKIPA Pharma Inc. (HOOK) Insider Monkey +9.03%
Jun-11-20 08:34AM	Why HOOKIPA (HOOK) Stock Might be a Great Pick Zacks -10.92%
May-26-20 07:30AM	HOOKIPA Pharma to Present at Jefferies Virtual Healthcare Conference GlobeNewswire
May-17-20 09:31AM	HOOKIPA Pharma Inc. (NASDAQ:HOOK) First-Quarter Results: Here's What Analysts Are Forecasting For This Year Simply Wall St.
May-14-20 08:15AM	HOOKIPA Pharma Inc (HOOK) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:00AM	HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update GlobeNewswire
May-07-20 12:30PM	Will HOOKIPA Pharma Inc (HOOK) Report Negative Earnings Next Week? What You Should Know Zacks
May-04-20 07:00AM	HOOKIPA Pharma To Report First Quarter 2020 Financial Results on May 14, 2020 GlobeNewswire +5.65%
Apr-29-20 07:00AM	HOOKIPA Pharma to Present at Upcoming Conferences in May GlobeNewswire
Apr-21-20 07:00AM	HOOKIPA Pharma Announces Publication of HB-101 Phase 1 Results in The Journal of Infectious Diseases GlobeNewswire -5.60%
Apr-19-20 10:33AM	Did Changing Sentiment Drive HOOKIPA Pharma's (NASDAQ:HOOK) Share Price Down By 43%? Simply Wall St.
Mar-19-20 07:00AM	HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update GlobeNewswire -9.00%
06:00AM	HOOKIPA Pharma, Inc. to Host Earnings Call ACCESSWIRE
Mar-10-20 08:15AM	HOOKIPA Pharma To Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 19, 2020 GlobeNewswire
Feb-18-20 08:00AM	HOOKIPA Pharma to Present at SVB Leerink 9th Annual Global Healthcare Conference GlobeNewswire
Jan-15-20 09:53AM	Is HOOKIPA Pharma (NASDAQ:HOOK) Using Debt In A Risky Way? Simply Wall St.
Jan-06-20 07:00AM	HOOKIPAs Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry GlobeNewswire
Dec-30-19 07:30AM	HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers GlobeNewswire
Dec-20-19 02:27PM	Hedge Funds Have Never Been This Bullish On HOOKIPA Pharma Inc. (HOOK) Insider Monkey +5.95%
Nov-25-19 08:00AM	HOOKIPA Pharma to Present at Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire
Nov-12-19 04:01PM	HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update GlobeNewswire
Nov-04-19 08:00AM	HOOKIPA Pharma To Report Third Quarter 2019 Financial Results on November 12, 2019 GlobeNewswire -5.52%
Oct-31-19 08:15AM	HOOKIPA Pharma to Present at Upcoming Conferences in November GlobeNewswire
Sep-25-19 08:30AM	HOOKIPA Announces Key Hires to its Executive Team GlobeNewswire
Sep-19-19 08:55AM	HOOKIPA to Present Data Demonstrating the Potential of its TheraT® Technology at the Upcoming CICON Conference in Paris GlobeNewswire
Aug-29-19 08:30AM	HOOKIPA Pharma to Present at Upcoming Investor Conferences in September GlobeNewswire +9.44%
Aug-12-19 04:01PM	HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights GlobeNewswire
Jul-19-19 01:37PM	What Kind Of Shareholders Own HOOKIPA Pharma Inc. (NASDAQ:HOOK)? Simply Wall St. +5.31%
Jul-17-19 10:06AM	Biotech Stock Roundup: Galapagos & Hookipa Surge, AMGN Shelves Alzheimer's Study Zacks +10.77%
Jul-12-19 07:58AM	Dow Jones Futures: Illumina, Profitable Marijuana Stock Tumble; Amgen-Novartis Alzheimer's Drug Fails Investor's Business Daily +22.90%
07:24AM	The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study Benzinga
Jul-11-19 04:37PM	Hookipa Pharma jumps 40% after FDA approval of clinical tests MarketWatch
04:01PM	HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers GlobeNewswire
02:05PM	[video]Hookipa Soars on FDA OK of Early Stage Trial For Cancer Treatment TheStreet.com
Jun-10-19 09:10AM	CEO of Agrios Global Holdings Ltd. Presenting at The Advantage Strategy and Financial Conference June 14, 2019, in Vienna, Austria CNW Group +7.28%
May-20-19 04:01PM	HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights GlobeNewswire
May-08-19 03:47AM	HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead GlobeNewswire
Apr-25-19 08:30AM	HOOKIPA Appoints David R. Kaufman to its Board of Directors GlobeNewswire
Apr-18-19 11:01AM	Hookipa Pharma shares off to lackluster start in trading debut MarketWatch
07:26AM	5 things to know about Hookipa Pharma ahead of its IPO MarketWatch
Apr-17-19 10:49PM	HOOKIPA Pharma Announces Pricing of Initial Public Offering GlobeNewswire
Apr-14-19 09:53AM	IPO Outlook For The Week: Pinterest, Zoom, Biotechs, Minerals And Catastrophe Insurance Benzinga

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immune-therapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jul 20	Sale	11.94	12,483	149,102	3,948,091	Jul 22 04:03 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jun 29	Sale	11.78	3,280	38,628	3,960,574	Jul 22 04:03 PM
SOFINNOVA CAPITAL VI FCPR	10% Owner	Jun 29	Sale	11.78	3,280	38,628	3,960,574	Jul 01 04:16 PM
Matushansky Igor	Chief Medical Officer	Jan 29	Sale	12.73	5,500	69,992	53,398	Jan 31 04:01 PM
Lilja Anders	Sr. VP, Technical Development	Jan 23	Option Exercise	0.10	11,643	1,164	7,568	Jan 27 04:52 PM
Lilja Anders	Sr. VP, Technical Development	Jan 23	Sale	12.59	11,643	146,533	0	Jan 27 04:52 PM
Orlinger Klaus	Sr. VP, Research	Jan 21	Option Exercise	0.10	6,789	679	6,789	Jan 21 04:44 PM
Orlinger Klaus	Sr. VP, Research	Jan 21	Sale	12.02	6,789	81,592	0	Jan 21 04:44 PM
Orlinger Klaus	Sr. VP, Research	Jan 16	Option Exercise	0.10	1,711	171	1,711	Jan 21 04:44 PM
Orlinger Klaus	Sr. VP, Research	Jan 16	Sale	11.56	1,711	19,781	0	Jan 21 04:44 PM
Orlinger Klaus	Sr. VP, Research	Jan 14	Option Exercise	0.10	8,500	850	8,500	Jan 16 04:06 PM
Orlinger Klaus	Sr. VP, Research	Jan 14	Sale	11.30	8,500	96,053	0	Jan 16 04:06 PM
Matushansky Igor	Chief Medical Officer	Dec 19	Option Exercise	0.10	25,891	2,589	69,302	Dec 23 08:30 AM
Matushansky Igor	Chief Medical Officer	Dec 19	Sale	9.93	10,404	103,312	58,898	Dec 23 08:30 AM
Matushansky Igor	Chief Medical Officer	Dec 17	Option Exercise	0.10	26,312	2,631	54,895	Dec 19 04:03 PM
Matushansky Igor	Chief Medical Officer	Dec 17	Sale	7.87	11,484	90,379	43,411	Dec 19 04:03 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience